Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
CUMBERLAND PHARMACEUTICALS INC (CPIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
08/08/2023 8-K Quarterly results
06/30/2023 8-K Other Events  Interactive Data
06/07/2023 8-K Other Events  Interactive Data
06/02/2023 8-K Changes in Registrant's Certifying Accountant  Interactive Data
05/24/2023 8-K Changes in Registrant's Certifying Accountant  Interactive Data
05/16/2023 8-K Other Events  Interactive Data
Docs: "CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS"
05/09/2023 8-K Quarterly results
Docs: "Cumberland Pharmaceuticals Reports First Quarter 2023"
04/28/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/04/2023 8-K Other Events  Interactive Data
03/15/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "# # # #",
"# # # #",
"# # # #",
"# # # #",
"# # # #"
03/07/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022"
01/17/2023 8-K Quarterly results
12/12/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
08/09/2022 8-K Results of Operations and Financial Condition  Interactive Data
Docs: "Cumberland Pharmaceuticals Reports 14% Revenue Growth"
07/19/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
05/03/2022 8-K Quarterly results
04/25/2022 8-K Other Events  Interactive Data
03/22/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/17/2022 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Independent Auditors",
"REPORT OF INDEPENDENT AUDITORS",
"SANCUSO® PRODUCT LINE OF KYOWA KIRIN, INC.",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS"
03/17/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/08/2022 8-K Quarterly results
01/06/2022 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Fin...
Docs: "Asset Purchase Agreement, by and among Cumberland Pharmaceuticals Inc. and Kyowa Kirin, Inc., +",
"CUMBERLAND PHARMACEUTICALS ACQUIRES SANCUSO® FROM KYOWA KIRIN NORTH AMERICA"
01/03/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
12/27/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AMENDMENT NO. 1 TO AT MARKET ISSUANCE SALES AGREEMENT",
"1600 WEST END AVENUE"
11/19/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Cumberland Pharmaceuticals Moving Corporate Headquarters to Broadwest"
11/09/2021 8-K Quarterly results
Docs: "CUMBERLAND PHARMACEUTICALS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS & COMPANY UPDATE"
11/01/2021 8-K Entry into a Material Definitive Agreement  Interactive Data
08/10/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy